Li X, Chen L, Luan S, Zhou J, Xiao X, Yang Y, et al. The development and progress of nanomedicine for esophageal cancer diagnosis and treatment. Semin Cancer Biol. 2022;86:873–85.

Article  CAS  PubMed  Google Scholar 

Liu CQ, Ma YL, Qin Q, Wang PH, Luo Y, Xu PF, et al. Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040. Thorac Cancer. 2023;14:3–11.

Article  PubMed  Google Scholar 

Zhu H, Ma X, Ye T, Wang H, Wang Z, Liu Q, et al. Esophageal cancer in China: Practice and research in the new era. Int J Cancer. 2023;152:1741–51.

Article  CAS  PubMed  Google Scholar 

Smyth EC, Lagergren J, Fitzgerald RC, Lordick F, Shah MA, Lagergren P, et al. Oesophageal cancer. Nat Rev Dis Prim. 2017;3:17048.

Article  PubMed  Google Scholar 

Arnold M, Ferlay J, van Berge Henegouwen MI, Soerjomataram I. Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut. 2020;69:1564–71.

Article  PubMed  Google Scholar 

Li Q, Liu T, Ding Z. Neoadjuvant immunotherapy for resectable esophageal cancer: a review. Front Immunol. 2022;13:1051841.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu C, Liu Y, Ali NM, Zhang B, Cui X. The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy. Front Immunol. 2022;13:1039260.

Article  CAS  PubMed  Google Scholar 

Wang J, Gong R, Zhao C, Lei K, Sun X, Ren H. Human FOXP3 and tumour microenvironment. Immunology. 2023;168:248–55.

Article  CAS  PubMed  Google Scholar 

Tiwari A, Trivedi R, Lin SY. Tumor microenvironment: barrier or opportunity towards effective cancer therapy. J Biomed Sci. 2022;29:83.

Article  PubMed  PubMed Central  Google Scholar 

Mantovani A, Allavena P, Marchesi F, Garlanda C. Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov. 2022;21:799–820.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng K, Cai N, Zhu J, Yang X, Liang H, Zhang W. Tumor-associated macrophages in liver cancer: From mechanisms to therapy. Cancer Commun (Lond, Engl). 2022;42:1112–40.

Article  Google Scholar 

Wu K, Lin K, Li X, Yuan X, Xu P, Ni P, et al. Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment. Front Immunol. 2020;11:1731.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Allavena P, Digifico E, Belgiovine C. Macrophages and cancer stem cells: a malevolent alliance. Mol Med (Camb, Mass). 2021;27:121.

Article  CAS  PubMed  Google Scholar 

Kerneur C, Cano CE, Olive D. Major pathways involved in macrophage polarization in cancer. Front Immunol. 2022;13:1026954.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang H, Yung MMH, Ngan HYS, Chan KKL, Chan DW. The impact of the tumor microenvironment on macrophage polarization in cancer metastatic progression. Int J Mol Sci. 2021;22:6560.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nowak M, Klink M. The role of tumor-associated macrophages in the progression and chemoresistance of ovarian cancer. Cells. 2020;9:1299.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Masetti M, Carriero R, Portale F, Marelli G, Morina N, Pandini M, et al. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer. J Exp Med. 2022;219:e20210564.

Article  CAS  PubMed  Google Scholar 

Liu M, Liu L, Song Y, Li W, Xu L. Targeting macrophages: a novel treatment strategy in solid tumors. J Transl Med. 2022;20:586.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen S, Saeed A, Liu Q, Jiang Q, Xu H, Xiao GG, et al. Macrophages in immunoregulation and therapeutics. Signal Transduct Target Ther. 2023;8:207.

Article  PubMed  PubMed Central  Google Scholar 

Tang B, Zhu J, Wang Y, Chen W, Fang S, Mao W, et al. Targeted xCT-mediated ferroptosis and protumoral polarization of macrophages is effective against hcc and enhances the efficacy of the anti-PD-1/L1 response. Adv Sci (Weinh, Baden-Wurtt, Ger). 2023;10:e2203973.

Google Scholar 

Tan Y, Zhao L, Yang YG, Liu W. The role of osteopontin in tumor progression through tumor-associated macrophages. Front Oncol. 2022;12:953283.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wai PY, Kuo PC. The role of osteopontin in tumor metastasis. J Surg Res. 2004;121:228–41.

Article  CAS  PubMed  Google Scholar 

Yokosaki Y, Tanaka K, Higashikawa F, Yamashita K, Eboshida A. Distinct structural requirements for binding of the integrins alphavbeta6, alphavbeta3, alphavbeta5, alpha5beta1 and alpha9beta1 to osteopontin. Matrix Biol: J Int Soc Matrix Biol. 2005;24:418–27.

Article  CAS  Google Scholar 

Lamort AS, Giopanou I, Psallidas I, Stathopoulos GT. Osteopontin as a link between inflammation and cancer: the thorax in the spotlight. Cells. 2019;8:815.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Song Z, Chen W, Athavale D, Ge X, Desert R, Das S, et al. Osteopontin takes center stage in chronic liver disease. Hepatology. 2021;73:1594–608.

Article  PubMed  Google Scholar 

Zhu Y, Yang J, Xu D, Gao XM, Zhang Z, Hsu JL, et al. Disruption of tumour-associated macrophage trafficking by the osteopontin-induced colony-stimulating factor-1 signalling sensitises hepatocellular carcinoma to anti-PD-L1 blockade. Gut. 2019;68:1653–66.

Article  CAS  PubMed  Google Scholar 

Tang H, Chen J, Han X, Feng Y, Wang F. Upregulation of SPP1 is a marker for poor lung cancer prognosis and contributes to cancer progression and cisplatin resistance. Front Cell Dev Biol. 2021;9:646390.

Article  PubMed  PubMed Central  Google Scholar 

Wei J, Marisetty A, Schrand B, Gabrusiewicz K, Hashimoto Y, Ott M, et al. Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target. J Clin Invest. 2019;129:137–49.

Article  PubMed  Google Scholar 

Choe EK, Yi JW, Chai YJ, Park KJ. Upregulation of the adipokine genes ADIPOR1 and SPP1 is related to poor survival outcomes in colorectal cancer. J Surg Oncol. 2018;117:1833–40.

Article  CAS  PubMed  Google Scholar 

Deng G, Zeng F, Su J, Zhao S, Hu R, Zhu W, et al. BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway. Theranostics. 2020;10:11428–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qian J, LeSavage BL, Hubka KM, Ma C, Natarajan S, Eggold JT, et al. Cancer-associated mesothelial cells promote ovarian cancer chemoresistance through paracrine osteopontin signaling. J Clin Invest. 2021;131:e146186.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yi X, Luo L, Zhu Y, Deng H, Liao H, Shen Y, et al. SPP1 facilitates cell migration and invasion by targeting COL11A1 in lung adenocarcinoma. Cancer Cell Int. 2022;22:324.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao H, Chen Q, Alam A, Cui J, Suen KC, Soo AP, et al. The role of osteopontin in the progression of solid organ tumour. Cell Death Dis. 2018;9:356.

Article  PubMed  PubMed Central  Google Scholar 

Liu T, Wu H, Qi J, Qin C, Zhu Q. Seven immune-related genes prognostic power and correlation with tumor-infiltrating immune cells in hepatocellular carcinoma. Cancer Med. 2020;9:7440–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clemente N, Raineri D, Cappellano G, Boggio E, Favero F, Soluri MF, et al. Osteopontin bridging innate and adaptive immunity in autoimmune diseases. J Immunol Res. 2016;2016:7675437.

Article  PubMed  PubMed Central  Google Scholar 

Morimoto J, Kon S, Matsui Y, Uede T. Osteopontin; as a target molecule for the treatment of inflammatory diseases. Curr Drug Targets. 2010;11:494–505.

Article  CAS  PubMed  Google Scholar 

Shurin MR. Osteopontin controls immunosuppression in the tumor microenvironment. J Clin Investig. 2018;128:5209–12.

Article  PubMed  PubMed Central